In 2006, Dr. Shyam Mohapatra initiated major research grants to develop siRNA-based prophylactics for respiratory syncytial virus (RSV). He secured a VA Merit Review award (April 2005–March 2009) to...
In 2007, Dr. Shyam Mohapatra received the Department of Veterans Affairs Research Career Scientist Award from the Biomedical Laboratory Research and Development Service at the James A. Haley VA...
In February 2013, Dr. Shyam Mohapatra was inducted as a Charter Fellow of the National Academy of Inventors. This distinction recognizes prolific innovators whose inventions have a tangible impact on...
In July 2014, Dr. Shyam Mohapatra was among the six inaugural inductees into the Florida Inventors Hall of Fame. He was recognized for pioneering nanotechnology-based diagnostics and treatments for...
In 2015, the American Institute for Medical and Biological Engineering (AIMBE) announced that Dr. Shyam Mohapatra would be inducted into its prestigious College of Fellows. The honor recognizes his...
In 2016, Dr. Shyam Mohapatra was elected a Fellow of the American Association for the Advancement of Science (AAAS) for his outstanding contributions to pharmaceutical sciences and nanotechnology...
Dr. Shyam Mohapatra founded and directs the VA Colorectal Cancer Cell-Genomics Consortium (VA4C), established in 2017. This national Veterans Affairs network applies precision medicine to colorectal...
In 2025, USF Health announced that Dr. Subhra Mohapatra—spouse of Dr. Shyam Mohapatra—was inducted into the Florida Inventors Hall of Fame. Her pioneering work in nanotechnology and molecular medicine...
On April 26, 2014, Dr. Shyam Mohapatra—Associate Dean at the University of South Florida and co‑founder of TransGenex Nanobiotech—was honored with the Global Corporate Award in Nanotechnology.
USF Health announced that the National Institutes of Health awarded a $3.75 million research grant to a multidisciplinary team to investigate whether Long COVID contributes to Alzheimer’s disease and...
